Tomasz Bednarczuk
Overview
Explore the profile of Tomasz Bednarczuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
1282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papini E, Attanasio R, Zarkovic M, Nagy E, Negro R, Perros P, et al.
Endocrine
. 2024 Aug;
87(1):262-272.
PMID: 39217207
Background: Treatment of simple goiter (SG) growing over time with thyroid hormone (TH) therapy is discouraged by international guidelines. Purpose: To ascertain views of European thyroid specialists about TH treatment...
2.
Kus A, Sterenborg R, Haug E, Galesloot T, Visser W, Smit J, et al.
Thyroid
. 2024 Jun;
34(8):969-979.
PMID: 38919119
Serum thyroid-stimulating hormone (TSH) measurement is the diagnostic cornerstone for primary thyroid dysfunction. There is high inter-individual but limited intra-individual variation in TSH concentrations, largely due to genetic factors. The...
3.
Negro R, Zarkovic M, Attanasio R, Hegedus L, Nagy E, Papini E, et al.
Clin Endocrinol (Oxf)
. 2024 Jun;
101(2):180-190.
PMID: 38856700
Objectives: The use of levothyroxine (LT4) treatment aiming to improve fertility in euthyroid women with positive thyroid peroxidase antibodies (TPOAb) is not supported by the available evidence. The aim of...
4.
Rymuza J, Kus A, Bialas-Niedziela D, Turczynska M, Kecik D, Bednarczuk T
Endokrynol Pol
. 2024 Mar;
75(1):117-118.
PMID: 38497401
Not required for Clinical Vignettes.
5.
Attanasio R, Zarkovic M, Papini E, Nagy E, Negro R, Perros P, et al.
Thyroid
. 2024 Feb;
34(4):429-441.
PMID: 38368541
Hypothyroidism is common, however, aspects of its treatment remain controversial. Our survey aimed at documenting treatment choices of European thyroid specialists and exploring how patients' persistent symptoms, clinician demographics, and...
6.
Zarkovic M, Attanasio R, Nagy E, Negro R, Papini E, Perros P, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1225202.
PMID: 38027187
Introduction: Thyroid specialists influence how hypothyroid patients are treated, including patients managed in primary care. Given that physician characteristics influence patient care, this study aimed to explore thyroid specialist profiles...
7.
Bednarczuk T, Kajdaniuk D, Marek B, Bolanowski M, Dedecjus M, Gilis-Januszewska A, et al.
Endokrynol Pol
. 2023 Feb;
74(1):1-4.
PMID: 36847719
Medical practice involves a high number of radiological examinations using iodinated contrast media (ICM). Therefore, it is crucial for doctors of different specialties to be aware of possible adverse effects...
8.
Radziszewski M, Kus A, Bednarczuk T
Best Pract Res Clin Endocrinol Metab
. 2023 Feb;
37(2):101745.
PMID: 36828713
Graves' disease (GD) is a heterogeneous autoimmune disease affecting with varying degrees of severity the thyroid gland, orbital tissues and skin. The pathogenesis of GD involves a complex interplay between...
9.
Burch H, Perros P, Bednarczuk T, Cooper D, Dolman P, Leung A, et al.
Thyroid
. 2022 Dec;
32(12):1439-1470.
PMID: 36480280
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop...
10.
Burch H, Perros P, Bednarczuk T, Cooper D, Dolman P, Leung A, et al.
Eur Thyroid J
. 2022 Dec;
11(6).
PMID: 36479875
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop...